Figure 2.
Figure 2. Heparin-independent serum-induced serotonin release. (A) SRA results using serial fourfold serum dilutions for 4 MM patients who developed HIT. All 4 patient sera showed strong serum-induced serotonin release (>80%) using 1/2 diluted serum (heparin-independent serotonin release); at higher dilutions, as expected, typical heparin-dependent serotonin release (at 0.2 IU/mL UFH) was shown, with serotonin-release inhibited at 100 IU/mL UFH. (B) SRA results using serial fourfold serum dilutions for 2 positive autoimmune HIT controls. Both sera were available from previously reported patients with delayed-onset HIT (patient 115) and persisting HIT.16 (C) Relationship of platelet count recovery with decrease of heparin-independent serum-induced serotonin release. For 2 patients (1 and 4) for whom follow-up sera were available, platelet count recovery occurred in association with decrease in heparin-independent serum-induced serotonin release.

Heparin-independent serum-induced serotonin release. (A) SRA results using serial fourfold serum dilutions for 4 MM patients who developed HIT. All 4 patient sera showed strong serum-induced serotonin release (>80%) using 1/2 diluted serum (heparin-independent serotonin release); at higher dilutions, as expected, typical heparin-dependent serotonin release (at 0.2 IU/mL UFH) was shown, with serotonin-release inhibited at 100 IU/mL UFH. (B) SRA results using serial fourfold serum dilutions for 2 positive autoimmune HIT controls. Both sera were available from previously reported patients with delayed-onset HIT (patient 115 ) and persisting HIT.16  (C) Relationship of platelet count recovery with decrease of heparin-independent serum-induced serotonin release. For 2 patients (1 and 4) for whom follow-up sera were available, platelet count recovery occurred in association with decrease in heparin-independent serum-induced serotonin release.

Close Modal

or Create an Account

Close Modal
Close Modal